ASYMPTOTE GENETIC MEDICINES

Live / Applied — First extension granted (statement of use) (as of 10 Mar 2026)

What this means for you

Not registered yet, but its 20 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98915361
Mark type
Stylized text
Filed
20 Dec 2024
Published for opposition
15 Jul 2025
Attorney of record
Jonathan Pearce

Goods and services

  • Class 042 — Scientific and technological services: Biological research; Biological research and analysis; Development of gene-based medicines; Gene therapy research; Laboratory research services in the field of gene expression; Medical research; Medical research services; Research in the field of gene editing technology; Research in the field of synthetic biology; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for engaging in biological, medical, and gene therapy research; Software as a service (SAAS) services, namely, hosting software for use by others for engaging in biological, medical, and gene therapy research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Owner

Prosecution history

  • 10 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 10 Mar 2026 — SOU EXTENSION 1 GRANTED
  • 09 Mar 2026 — SOU EXTENSION 1 FILED
  • 09 Mar 2026 — SOU TEAS EXTENSION RECEIVED
  • 09 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 15 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 15 Jul 2025 — PUBLISHED FOR OPPOSITION
  • 09 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 13 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 13 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 12 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 12 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 10 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 10 Jun 2025 — NON-FINAL ACTION E-MAILED
  • 10 Jun 2025 — NON-FINAL ACTION WRITTEN

View this trademark record on Marksy